Angiogenesis related Compound Library
Ref. TM-L4800
1mg | To inquire | |
30µl*10 (DMSO) | To inquire | |
50µl*10 (DMSO) | To inquire | |
100µl*10 (DMSO) | To inquire | |
250µl*10 (DMSO) | To inquire |
Product Information
A unique collection of 1370 proangiogenic and antiangiogenic compounds for new targets identification, research in mechanisms of angiogenesis, and high throughput screening (HTS) and high content screening (HCS);
- Targets include angiogenesis signaling, and related targets such as S1P, VEGFR, PDGF, etc.;
- Includes approved drugs targeting angiogenesis, such as Sunitinib Malate, Lenalidomide, sorafenib, Erlotinib; drugs in clinical development with the most potential targeting angiogenesis, such as Vatalanib, Orantinib, 2-Methoxyestradiol (Panzem), Celecoxib;
- Detailed compound information with structure, target, activity, IC50 value, and biological activity description;
- Structurally diverse, medicinally active, and cell permeable;
- NMR and HPLC validated to ensure high purity and quality;
Chemical properties
Technical inquiry about: TM-L4800 Angiogenesis related Compound Library
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.